Home

I recently got my CEA test done, and the results were detailed and easy to understand. The report provided valuable insights into cancer markers and health monitoring. It was professional, precise, and helped guide my next medical steps. Highly recommend this service for reliable health diagnostics!

The attached medical report belongs to a 73-year-old male patient and indicates an elevated CA 19-9 level of 38.7 U/mL reference range 37.0 U/mL CA 19-9 is a tumor marker commonly associated with pancreatic cancer and other malignancies. Elevated levels may also suggest colorectal cancer or non-cancerous conditions.

This laboratory report presents the findings of a Pap smear test conducted on a 56-year-old female patient. The smear was deemed satisfactory for evaluation, revealing an atrophic smear with no intraepithelial lesion or malignancy. The sample showed squamous epithelial cells, endocervical clusters, and scattered neutrophils.

This biochemistry report details the serum CEA (Carcinoembryonic Antigen) test results for a 51-year-old male diagnosed with colon adenocarcinoma. The CEA level is 1.79 ng/mL, within the biological reference range (0-3.8 ng/mL). The report emphasizes that this test is not a cancer screening tool and should be interpreted alongside other diagnostic methods.

The medical report details a 42-year-old male diagnosed with pancreatic carcinoma with liver metastases. Investigations, including USG, CECT, and liver biopsy, confirm malignancy. CA 19-9 tumor marker tests on 15/10/2024 (32.45 U/mL) and 23/03/2025 (12.10 U/mL) aid in monitoring. The report tracks disease progression and treatment response.